SGA
MRTX

Sector Gamma AS’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Sector Gamma AS’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,875
Closed -$976K – 43
2022
Q1 		$976K Sell
11,875
-14,231
-55% -$1.46M 0.21% 40
2021
Q4 		$3.83M Buy
26,106
+106
+0.4% +$16.5K 0.9% 29
2021
Q3 		$4.6M Buy
+26,000
New +$4.18M 0.92% 28

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Sector Gamma AS's MRTX Position: Q2 2022 in Review

Sector Gamma AS sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2022, closing a stake of 11,875 shares — an estimated $976K sold.

Sector Gamma AS first reported a position in MRTX in Q3 2021 and held it in 3 quarters. The position peaked at $4.6M in Q3 2021. 230 funds tracked by Wall St. Rank hold MRTX as of Q2 2022.

  • Sector Gamma AS reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Sector Gamma AS sold 11,875 Mirati Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $976K.
  • Sector Gamma AS first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Sector Gamma AS's Mirati Therapeutics, Inc. Common Stock position peaked at $4.6M in Q3 2021.
  • 230 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Sector Gamma AS's 13F filing for Q2 2022, filed 5 Aug 2022.